Blaise Coleman, EVP disclosed the purchase of 6,500 shares of (ENDP). The shares were purchased at an average price of $7.89. The EVP now owns $108,322 of the stock per the Form 4 SEC filing. Terrance J. Coughlin, EVP acquired …
Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes. All other quotes are delayed …
Just three months ago, an independent panel found the drug's benefits no longer exceed its risks. As such, ENDP stock is down 12.1% at $12.11, and Stifel downgraded the shares to "hold" from "buy," while trimming its price target to $15 …
Endo Pharmaceuticals Holdings Inc (ENDP): ENDP stock is up 1.6% today ... Article printed from InvestorPlace Media, http://investorplace.com/2015/08/hottest-healthcare-stocks-now-pbyi-nktr-endp-ipxl-pbyi-nktr-endp/.
Day trading stock picks likely to move big (up or down) during the week of August 29: $HTZ $CBI $SNAP $OAS $ENDP $OCLR $NBR $SWN $MOMO $AKS $FIT …
Wall Street analysts are expecting $4.50 in earnings per share for this year, placing Endo Health Solutions Inc (NASDAQ:ENDP)’s stock price at a current-year P/E multiple of only 8. The sell-side is projecting EPS to decline in the …
Cytori Therapeutics Inc. (NASDAQ: CYTX), Endo Health Solutions Inc. (NASDAQ: ENDP), Keryx Biopharmaceuticals ... This is now about 5-times normal trading volume and the stock hit a yearly high of $14.07 earlier in the day. This move …
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. …
On June 8, the FDA asked Endo International Plc (ENDP) to voluntarily withdraw its opioid agonist ... its shares fell only 5 percent on Friday. However, Depomed's stock price is down nearly 45 percent through June 9. Insys Therapetics Inc. …